[HTML][HTML] Best practices recommendations for diagnostic immunohistochemistry in lung cancer

Y Yatabe, S Dacic, AC Borczuk, A Warth… - Journal of thoracic …, 2019 - Elsevier
Since the 2015 WHO classification was introduced into clinical practice,
immunohistochemistry (IHC) has figured prominently in lung cancer diagnosis. In addition to …

Histopathology and genetic biomarkers of choroidal melanoma

G Broggi, A Russo, M Reibaldi, D Russo, S Varricchio… - Applied Sciences, 2020 - mdpi.com
Choroidal melanoma (CM), despite its rarity, is the most frequent intraocular malignancy.
Over time, several histological variants of CM have been distinguished, including spindle A …

Pan-cancer analysis of advanced patient tumors reveals interactions between therapy and genomic landscapes

E Pleasance, E Titmuss, L Williamson, H Kwan… - Nature Cancer, 2020 - nature.com
Advanced and metastatic tumors with complex treatment histories drive cancer mortality.
Here we describe the POG570 cohort, a comprehensive whole-genome, transcriptome and …

The role of SOX family in cancer stem cell maintenance: With a focus on SOX2

F Pouremamali, V Vahedian, N Hassani… - … -Research and Practice, 2022 - Elsevier
The role of cancer stem cells (CSCs) in cancer incidence, drug resistance, and relapse after
chemotherapy has been discussed and it has been confirmed that CSCs are extremely …

SOX10, GATA3, GCDFP15, androgen receptor, and mammaglobin for the differential diagnosis between triple-negative breast cancer and TTF1-negative lung …

E Laurent, H Begueret, B Bonhomme… - The American journal …, 2019 - journals.lww.com
Triple-negative breast cancer (TNBC) patients have an increased risk of developing visceral
metastases and other primary nonbreast cancers, particularly lung cancer. The differential …

Clinical implications of androgen-positive triple-negative breast cancer

M Brumec, M Sobočan, I Takač, D Arko - Cancers, 2021 - mdpi.com
Simple Summary Triple-negative breast cancer (TNBC) represents a heterogeneous group
of breast cancers that lack estrogen receptor (ER), progesterone receptor (PR), and human …

Combined SOX10 GATA3 is most sensitive in detecting primary and metastatic breast cancers: a comparative study of breast markers in multiple tumors

C Aphivatanasiri, J Li, R Chan, SK Jamidi… - Breast cancer research …, 2020 - Springer
Purpose For invasive breast cancer (IBC), high SOX10 expression was reported particularly
in TNBC. This raised the possibility that SOX10 may complement other breast markers for …

Emerging role of SOX proteins in breast cancer development and maintenance

GA Mehta, P Khanna, ML Gatza - Journal of mammary gland biology and …, 2019 - Springer
The SOX genes encode a family of more than 20 transcription factors that are critical
regulators of embryogenesis and developmental processes and, when aberrantly …

Sry‐related high‐mobility‐group/HMG box 10 (SOX10) as a sensitive marker for triple‐negative breast cancer

SK Jamidi, J Hu, C Aphivatanasiri, JY Tsang… - …, 2020 - Wiley Online Library
Aims Confirmation of a breast origin for triple‐negative breast cancer (TNBC) is sometimes
problematic. The traditional breast markers GATA‐binding protein 3 (GATA3), mammaglobin …

Utility of TRPS-1 immunohistochemistry in diagnosis of metastatic breast carcinoma in cytology specimens

M Abdelwahed, N Yurtsever, D Savant, P Karam… - Journal of the American …, 2022 - Elsevier
Introduction At present, GATA binding protein 3 (GATA-3) is the most frequently used
diagnostic immunohistochemical (IHC) marker for breast carcinoma (BC). However, it is not …